Cargando…
Future of HIV2 and HIV2 + 1 Infected Patients Treated with Antiretrovirals Followed at the Day Hospital HIV Care Unit from 2011 to 2015
Introduction: HIV2 is endemic in West Africa. In Burkina Faso, its prevalence was estimated at 2%. The aim of this work was to evaluate the follow-up of patients and also to contribute to the availability of data. Methods: We involved 18 years or older. Infection was screened according to the nation...
Autores principales: | Diallo, Ismaël, Ouédraogo, Smaïla, Sawadogo, Abdoulaye, Ouédraogo, Gafourou Arsène, Diendéré, Eric Arnaud, Zoungrana, Jacques, Sondo, Apoline Kongnimissom, Bognounou, Réné, Savadogo, Mamoudou, Poda, Armel, Drabo, Youssouf Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732798/ https://www.ncbi.nlm.nih.gov/pubmed/36474417 http://dx.doi.org/10.1177/23259582221143675 |
Ejemplares similares
-
Dengue infection during pregnancy in Burkina Faso: a cross-sectional study
por: Sondo, Kongnimissom Apoline, et al.
Publicado: (2019) -
Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): Findings from hospital based cross-sectional study
por: Diendéré, Eric Arnaud, et al.
Publicado: (2021) -
Severe dengue in adults and children, Ouagadougou (Burkina Faso), West Africa, October 2015–January 2017
por: Sondo, Apoline Kongnimissom, et al.
Publicado: (2021) -
Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022) -
Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso
por: Kaboré, Mikaila, et al.
Publicado: (2022)